https://www.taxtmi.com/news?id=36421 A substantial rise in counterfeit and substandard medicines in retail markets is attributed to heavy discounting incentives, retail margin caps, easier interstate movement after tax harmonisation, and inadequate inspection and enforcement. The existing statutory penalties are viewed as insufficient and hard to apply where fatalities may occur, while central and state agencies lack resources and effective machinery to prevent distribution. Stakeholders urge stronger legal deterrents, enhanced quality control infrastructure, targeted enforcement against suspicious discounting and diversion, and public awareness to protect patient safety. en-us Thu, 06 Mar 2025 20:16:03 +0530 Thu, 06 Mar 2025 20:16:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=36421 A substantial rise in counterfeit and substandard medicines in retail markets is attributed to heavy discounting incentives, retail margin caps, easier interstate movement after tax harmonisation, and inadequate inspection and enforcement. The existing statutory penalties are viewed as insufficient and hard to apply where fatalities may occur, while central and state agencies lack resources and effective machinery to prevent distribution. Stakeholders urge stronger legal deterrents, enhanced quality control infrastructure, targeted enforcement against suspicious discounting and diversion, and public awareness to protect patient safety. News - Thu, 06 Mar 2025 20:16:03 +0530 https://www.taxtmi.com/news?id=36421